$MRK Recent Headlines Merck to revamp its RD practices:

New Post Public Reply Private Reply Replies (0) Message Board

Dec 28, 2013 at 3:51 PM

$MRK Recent Headlines

Merck to revamp its R&D practices: WSJ 4:49 p.m. Dec. 27, 2013 - Wallace Witkowski
Merck to radically reshape R&D unit: WSJ 4:40 p.m. Dec. 27, 2013 - Wallace Witkowski
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
EU approves Merck's Erbitux for cancer treatment 4:52 a.m. Dec. 23, 2013 - MarketWatch.com
Biotechs continue to pay off 10:27 a.m. Dec. 20, 2013 - The Trading Deck
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Merck, McDonald's are top decliners in Dow index 4:05 p.m. Dec. 4, 2013 - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin

Why Merck Is Planning to Change Its Research Strategy 2:05 p.m. Today - Wall St. Cheat Sheet
Merck Plans Radical Overhaul of Drug R&D Unit 5:20 p.m. Dec. 27, 2013 - WSJ.com
New Drugs Could Change Cancer Landscape In 2014 5:20 p.m. Dec. 27, 2013 - Investors Business Daily
Ad Com scheduled for Merck's ragweed immunotherapy 8:36 a.m. Dec. 27, 2013 - Seeking Alpha
Merck Sues to Stop Generic NuvaRing 3:50 p.m. Dec. 26, 2013 - benzinga.com
Merck Becomes #15 Most Shorted Dow Stock, Replacing Johnson & Johnson 11:17 a.m. Dec. 26, 2013 - TheStreet.com
Dow Today: Microsoft Corporation (MSFT) Leads The Day Higher, Merck (MRK) Lags 10:00 a.m. Dec. 26, 2013 - TheStreet.com
Merck Sues Actavis Over Generic NuvaRing 9:44 a.m. Dec. 25, 2013 - Wall St. Cheat Sheet
Dividends: Big Dogs, Small Dogs And Spy Dogs 4:11 a.m. Dec. 25, 2013 - Seeking Alpha
Will Merck Be Able To Sustain Its Dividends? 3:55 p.m. Dec. 24, 2013 - Seeking Alpha
TESARO Plunges on Study Results - Analyst Blog 11:30 a.m. Dec. 24, 2013 - Zacks.com
Where Will GlaxoSmithKline Go Next? 10:50 a.m. Dec. 24, 2013 - Wall St. Cheat Sheet
Dow Dogs Drink To A Dominant 2013. Will They Toast A Triumphant 2014, Too? 10:38 a.m. Dec. 24, 2013 - Seeking Alpha
Cervical Cancer Should Not Be Ignored By Biotech Investors 9:59 a.m. Dec. 24, 2013 - Seeking Alpha
Actavis unit gets CRL for contraceptive patch, files ANDA for generic NuvaRing 9:12 a.m. Dec. 24, 2013 - Seeking Alpha
Big Pharma Stocks: Year in Review 6:00 a.m. Dec. 24, 2013 - TheStreet.com
48 Last-Minute Trades Before Christmas 4:07 a.m. Dec. 24, 2013 - InvestorPlace.com
Update on Sanofi/REGN's Alirocumab - Analyst Blog 5:20 p.m. Dec. 23, 2013 - Zacks.com
Gilead Sciences And The Numbers Game 9:51 a.m. Dec. 23, 2013 - Seeking Alpha
Top 10 Dow Dividend Stocks for December 6:00 a.m. Dec. 23, 2013 - InvestorPlace.com

New Business Ventures, Quarterly Dividends, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, DENTSPLY, Pharmacyclics, and St. Jude Medical 8:00 a.m. Dec. 25, 2013 - PR Newswire
Actavis Confirms Generic NuvaRing® Patent Challenge 9:00 a.m. Dec. 24, 2013 - PR Newswire
New Clinical Trials, Stock Price Movements, and Completed Acquisitions - Research Report on Merck, Lilly, Allergan, PerkinElmer, and Air Methods 8:00 a.m. Dec. 23, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Merck Announces Launch of a New Business Focused on Comprehensive, Evidence-Based Weight Management Interventions in the U.S. 9:00 a.m. Dec. 20, 2013 - BusinessWire
Critical Alerts For eBay, Merck, Michael Kors, Delta Air Lines, and Tiffany Released By InvestorsObserver 9:31 a.m. Dec. 19, 2013 - PR Newswire
Merck Enters Into License Agreement With the Spanish National Cancer Research Centre (CNIO) 10:00 a.m. Dec. 18, 2013 - PR Newswire
Merck Collaborates with GlaxoSmithKline to Evaluate Novel Combination Regimen for Advanced Renal Cell Carcinoma 7:30 a.m. Dec. 18, 2013 - BusinessWire
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development 8:01 a.m. Dec. 17, 2013 - Marketwire
Advisory Committee Recommendations, Voting Outcomes, New Appointments, and Stock Price Movements - Research Report on Merck, Bristol-Myers Squibb, Boston Scientific, WellCare, and PAREXEL 8:00 a.m. Dec. 17, 2013 - PR Newswire
MSD Animal Health Receives Positive Opinion from European Medicines Agency for BRAVECTO(TM) (fluralaner) 4:00 a.m. Dec. 17, 2013 - BusinessWire
When Prescribing New Drugs for Crohn's Disease or Ulcerative Colitis, Surveyed EU5 Gastroenterologists Will Prioritize Remission Rates Over Cost and Reimbursement Hurdles 8:00 a.m. Dec. 16, 2013 - PR Newswire
Clinical Studies Updates, and Stock Price Movements - Research Report on Merck, Select Medical Holdings, Galena Biopharma, Dendreon, and Echo Therapeutics 8:00 a.m. Dec. 16, 2013 - PR Newswire
Merck Statement on FDA Advisory Committee for GRASTEK(R) (Timothy Grass Pollen Allergen Extract), Merck's Investigational Sublingual Allergy Immunotherapy Tablet 7:17 p.m. Dec. 12, 2013 - BusinessWire
FDA Advisory Committee meeting unanimously recommends approval of GRASTEK (GRAZAX(R)) 4:13 p.m. Dec. 12, 2013 - GlobeNewswire
Heska Announces Extension of Tri-Heart(TM) Plus Heartworm Preventive Agreement with Merck Animal Health 9:00 a.m. Dec. 12, 2013 - PR Newswire
Reports, Positive Results, Updated Clinical Safety and Efficacy Data by Healthcare Companies - Research Report on Johnson & Johnson, Merck, BioMarin, Array BioPharma, and Brookdale Senior Living 8:00 a.m. Dec. 12, 2013 - PR Newswire
OncoSec Medical Announces Hire of Chief Medical Officer 6:05 a.m. Dec. 12, 2013 - BusinessWire
TechConnect World and National Innovation Summit Announce Lead Corporate Partners for 2014 10:00 a.m. Dec. 11, 2013 - PR Newswire
Pharma Industry Morning Assessment: Pfizer, Merck & Co., AbbVie, and Zogenix 12:19 p.m. Dec. 10, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tetragon's September Factsheet Offers Unique Insights

A Peek into Tetragon's Financial Playbook Every once in a while, you come across a player in the finance world that operates by its own rules. Tetragon Financial Group is one of those mavericks, and they've dropped their September 2026 Monthly Factsheet. Now here's a company that knows how to keep you guessing while serving up some real financial meat. Investment Strategy...

Intersignal's Braid 2.1 Unchains AI from the Cloud

Memory Capsules: A Game Changer in AI Intersignal LLC is stirring the AI pot again with its latest reveal, Braid 2.1. Right out of Fort Lauderdale, this edge AI power player is unleashing Memory Capsules, aiming to do away with the pesky cloud dependency for good. Picture this: your local AI instances now have the chops to carry a lasting, queryable memory—seriously,...

Chemical Industry Golf Event Raises $100,000 for STEM

Golf Goes Beyond the Green Picture this: industry bigwigs teeing off for a cause that actually matters. We're talking about the Swings for STEM golf tournament, where $100,000 was drummed up for the future minds that'll drive tomorrow's chemical industry. Now, that's what you call putting your money where your mouth is. This wasn't about boasting scores on the links; it...

Benewake Unveils SR Series LiDAR for Mobile Robots

Wave Goodbye to Bulky Sensors Hot off the Beijing press, Benewake's got something new—the SR Series 360° 3D LiDARs, set to stir up the robotics world. They're compact, power-efficient, and packed with smarts. It seems Benewake is tapping into a juicy market with these little sensors. Sleek Design and Big Promises The SR18 and SR96 models have a lot going for them. The...

Sonnenfeld, Curtis Shine in Honor of the Reiners' Legacy

Barry Sonnenfeld Takes Center Stage The spotlight is set for a different kind of blockbuster event—not on the silver screen this time, but under the starlit glamour of Beverly Hills. That's right, folks, Barry Sonnenfeld, the DGA and Emmy award-laden filmmaker we all know and love, will be the maestro hosting the Children's Institute's (CII) Cape & Gown Gala on November...

GAC All-New E8 Debuts at 2026 Macao Auto Expo

Revving Up at the Macao Auto Expo Sometimes it feels like the car game’s all about who can shout louder with a new model line-up. And there, under the bright lights of the Venetian Macao Cotai Expo, GAC rolled out their ALL-NEW E8. This wasn’t just another car in their roster; it's the symbol of their steady climb up the ranks and a nod to their decade-long presence...

24 Hour Fitness Pioneers New Club in Growing Summerlin

The Next Era of Fitness in Las Vegas Well, color me intrigued. Mark Mastrov, that pioneer behind 24 Hour Fitness, has got a new trick up his sleeve—and it's not your run-of-the-mill gym. Summerlin, Las Vegas will soon house the Founders Club, a beast of a fitness facility sprawling over 45,000 square feet. Talk about bringing big energy to a place that's already...

FDA Greenlights VELO: A Turning Point for Reynolds?

FDA Decision: A Big Win for Reynolds American Boy, am I seeing a shift in the winds. The FDA's green light for VELO nicotine pouches adds a fresh feather to Reynolds American's cap. In a gritty industry like tobacco, getting FDA's nod ain't just about safety; it’s a strategic leg up against traditional smoke. My gut tells me this isn't just about keeping pace. It's...

Cboe's Third Quarter Packs a Punch with Strong Gains

Making Waves in the Market There's no sugar-coating it—Cboe Global Markets has had a hell of a third quarter in 2026. With their diluted EPS climbing to a record $4.08, a 43% jump from last year, it's no surprise their stock ticker, CBOE, is catching some eyes. Adjusted diluted EPS also made a splash, soaring 36% to $3.63 compared to 2025 figures. Their strategic moves...

Hikvision Unveils AI Solutions Tailored for SMB Growth

Technology Geared for Practical Application Look, I’ve been around the tech block a few times, and Hikvision's latest shindig over in Hangzhou is causing a stir. Their third annual SMB gala isn't just lip service. We're talking about AI innovations meant to scratch where it actually itches for small businesses. The name of the game here is practical value. And yeah,...